Cargando…

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial

BACKGROUND: Lower respiratory tract infections like acute bronchitis, exacerbated chronic obstructive pulmonary disease and community-acquired pneumonia are often unnecessarily treated with antibiotics, mainly because of physicians' difficulties to distinguish viral from bacterial cause and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schuetz, Philipp, Christ-Crain, Mirjam, Wolbers, Marcel, Schild, Ursula, Thomann, Robert, Falconnier, Claudine, Widmer, Isabelle, Neidert, Stefanie, Blum, Claudine A, Schönenberger, Ronald, Henzen, Christoph, Bregenzer, Thomas, Hoess, Claus, Krause, Martin, Bucher, Heiner C, Zimmerli, Werner, Müller, Beat
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1947969/ https://www.ncbi.nlm.nih.gov/pubmed/17615073 http://dx.doi.org/10.1186/1472-6963-7-102

Ejemplares similares

Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections
por: Schuetz, Philipp, et al.
Publicado: (2010)

Effect of procalcitonin-based guidelines compared with standard guidelines on antibiotic use in lower respiratory tract infections: the randomized-controlled multicenter ProHOSP trial
por: Schuetz, P, et al.
Publicado: (2009)

Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients
por: Kutz, Alexander, et al.
Publicado: (2014)

The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study
por: Sbiti-Rohr, Diana, et al.
Publicado: (2016)

Which patients with lower respiratory tract infections need inpatient treatment? Perceptions of physicians, nurses, patients and relatives
por: Baehni, Claudia, et al.
Publicado: (2010)

Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: a 6-year prospective cohort study
por: Nickler, Manuela, et al.
Publicado: (2017)

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia
por: Baumgartner, Thomas, et al.
Publicado: (2018)

Dihydrotestosterone is a predictor for mortality in males with community-acquired pneumonia: results of a 6-year follow-up study
por: Zurfluh, Seline, et al.
Publicado: (2018)

Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia
por: Vögeli, Alaadin, et al.
Publicado: (2017)

Infection biomarkers in primary care patients with acute respiratory tract infections–comparison of Procalcitonin and C-reactive protein
por: Meili, Marc, et al.
Publicado: (2016)

Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter study
por: Suter-Widmer, Isabelle, et al.
Publicado: (2012)

Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]
por: Briel, Matthias, et al.
Publicado: (2005)

Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial
por: Blum, Claudine A, et al.
Publicado: (2014)

Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke
por: Blum, Claudine A., et al.
Publicado: (2013)

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm
por: Albrich, Werner C, et al.
Publicado: (2011)

Hyponatremia and anti-diuretic hormone in Legionnaires’ disease
por: Schuetz, Philipp, et al.
Publicado: (2013)

Association of Adrenal Function and Disease Severity in Community-Acquired Pneumonia
por: Mueller, Cornelia, et al.
Publicado: (2014)

Copeptin Levels Remain Unchanged during the Menstrual Cycle
por: Blum, Claudine A., et al.
Publicado: (2014)

Copeptin, Procalcitonin and Routine Inflammatory Markers–Predictors of Infection after Stroke
por: Fluri, Felix, et al.
Publicado: (2012)

No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial
por: Borisov, Angel N., et al.
Publicado: (2022)

Prognostic value of procalcitonin in respiratory tract infections across clinical settings
por: Kutz, Alexander, et al.
Publicado: (2015)

Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease
por: Schuetz, Philipp, et al.
Publicado: (2008)

Association of adrenal insufficiency with patient-oriented health-care outcomes in adult medical inpatients
por: Ebrahimi, Fahim, et al.
Publicado: (2019)

Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study
por: Odermatt, Jonas, et al.
Publicado: (2017)

Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis
por: Schuetz, Philipp, et al.
Publicado: (2012)

Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial
por: Raess, Natalie, et al.
Publicado: (2021)

Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the “Co-MED study”
por: Nigro, Nicole, et al.
Publicado: (2018)

Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial
por: Drozdov, Daniel, et al.
Publicado: (2015)

Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

Circulating Precursor Levels of Endothelin-1 and Adrenomedullin, Two Endothelium-Derived, Counteracting Substances, in Sepsis
por: Schuetz, Philipp, et al.
Publicado: (2007)

Validity of Different Copeptin Assays in the Differential Diagnosis of the Polyuria-Polydipsia Syndrome
por: Sailer, Clara Odilia, et al.
Publicado: (2021)

Procalcitonin-guided diagnosis and antibiotic stewardship revisited
por: Sager, Ramon, et al.
Publicado: (2017)

Copeptin: a new and promising diagnostic and prognostic marker
por: Katan, Mira, et al.
Publicado: (2008)

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
por: Schuetz, Philipp, et al.
Publicado: (2011)

BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events
por: Nigro, Nicole, et al.
Publicado: (2014)

SAT-066 Effect Of Interleukin-1-receptor Antagonist On Hemodynamics And Renin-angiotensin-aldosterone System In Obese Individuals
por: Urwyler, Sandrine, et al.
Publicado: (2019)

Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study
por: Blum, Claudine Angela, et al.
Publicado: (2017)

Effect of a clinical procalcitonin algorithm to guide antibiotic therapy in patients with lower respiratory tract infections outside study conditions: a post-study survey
por: Schuetz, P, et al.
Publicado: (2009)

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
por: Ebrahimi, Fahim, et al.
Publicado: (2021)

Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
por: Blum, CA, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oqc6b9anug3dv0rnnflo94d0bn